Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001936261 | SCV002201804 | uncertain significance | Fanconi anemia | 2023-07-10 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with aspartic acid, which is acidic and polar, at codon 1277 of the FANCM protein (p.Asn1277Asp). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The aspartic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 1428347). This variant has not been reported in the literature in individuals affected with FANCM-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.03%). |
Gene |
RCV003126007 | SCV003803163 | uncertain significance | not provided | 2024-02-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Identified in an individual with colorectal cancer (PMID: 34326862); This variant is associated with the following publications: (PMID: 34326862) |
Ambry Genetics | RCV003167308 | SCV003879114 | uncertain significance | Inborn genetic diseases | 2023-03-02 | criteria provided, single submitter | clinical testing | The c.3829A>G (p.N1277D) alteration is located in exon 14 (coding exon 14) of the FANCM gene. This alteration results from a A to G substitution at nucleotide position 3829, causing the asparagine (N) at amino acid position 1277 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003126007 | SCV004218785 | uncertain significance | not provided | 2023-11-06 | criteria provided, single submitter | clinical testing |